← Back
$TNGX All transactions

Tango Therapeutics, Inc.

A

$ Value

$0

Shares

1,650,000

Price

$0

Filed

Jan 12

Insider

Name

Peters Malte

Title

President & CEO

CIK

0001876563

Roles

Director Officer

Transaction Details

Transaction Date

2026-01-08

Code

A

Table

Derivative

Ownership

Direct

Equity Swap

No

Shares After

1,650,000

Footnotes

These shares are represented by restricted stock units (the "RSUs"). Each RSU represents a contingent right to receive one share of Common Stock of the Issuer. The RSUs will vest over a three year period at a rate of 33% on February 1, 2027, 33% on February 14, 2028 and 34% on February 12, 2029, subject to the Reporting Person's continuous service with the Issuer as of each such vesting date. | This option shall vest and become exercisable over a four-year period, with 25% vesting on January 8, 2027 and the remaining option shares vesting in 36 substantially equal monthly installments thereafter, subject to the Reporting Person's continuous service with the Issuer as of each such vesting date.

Filing Info

Accession No.

0001193125-26-009663

Form Type

4

Issuer CIK

0001819133

Peters Malte's History

Date Ticker Type Value
2026-01-08 TNGX A $0
2026-01-08 TNGX A $0
2025-11-03 TNGX A $0
2025-08-19 HOOK $21K
2025-07-22 HOOK $27K
2025-06-05 TNGX A $0
2025-06-05 TNGX A $0

Other Insiders at TNGX (90d)

Insider Bought Sold Last
Beckman Daniella
Chief Financial Officer
$127K 2026-02-03
Weber Barbara
Director, Executive Chair
$374K 2026-02-03
Crystal Adam
President, R&D
$3.0M 2026-04-15